Who Are We?

ForDoz Pharma is an innovative commercial-stage pharmaceutical company based in East Windsor, NJ. We focus on developing, manufacturing, and commercializing innovative complex injectables for patients with severe and chronic diseases.

ForDoz was founded in 2014 to help address significant unmet medical needs. The company aims to accelerate the development of innovative complex injectable medicines and therapies. ForDoz’s experienced team has successfully developed proprietary particle-based drug delivery technology and Long-Acting Injectables (LAI) platforms, generating a broad pipeline of generic complex injectables as well as innovative better complex injectables via 505(b)(2) regulatory pathway.

We successfully built and now operate a state-of-the-art cGMP sterile manufacturing facility and have one liposomal injectable oncology product approved and launched in the U.S. ForDoz has supplemented its pipeline with patented innovative long-acting injectables (LAI) focusing on chronic disease via 505(b)(2). At the same time, our CDMO services help other companies develop and manufacture complex injectables.

ForDoz Pharma is a fully integrated pharmaceutical company with end-to-end capabilities. ForDoz has an internal R&D team to advance innovative products, a well-experienced quality and production team with a unique cGMP sterile manufacturing facility, an experienced regulatory affairs group, and highly specialized commercial marketing and sales partners worldwide. This integrated approach provides sustainable competitive advantages for ForDoz and its partners.